Interrelation of lymphocyte subpopulations in peripheral blood under cervical papillomavirus infection. 1999

Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kiev, Ukraine.

T(CD3+)-, B(CD19+)-lymphocytes and their subsets (CD4+, CD8+, CD3+ DR+, CD3- DR+) in peripheral blood of patients with CIN I, CIN II, CIN III and cancer in situ associated with HPV infection were evaluated. In peripheral blood of women with CIN II, CIN III and cancer in situ the number of T-lymphocytes which expressed CD3+ DR+ antigen decreased. In patients with CIN I, CIN III and cancer in situ the level of the CD4+ cells decreased; the level of the CD8+ cells increased. These patients had a lower CD4/CD8 ratio, the number of B cells being standard. The results may have important implications in the prognosis and immunotherapy of HPV infection.

UI MeSH Term Description Entries
D002278 Carcinoma in Situ A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. Carcinoma, Intraepithelial,Carcinoma, Preinvasive,Intraepithelial Neoplasms,Neoplasms, Intraepithelial,Intraepithelial Carcinoma,Intraepithelial Neoplasm,Neoplasm, Intraepithelial,Preinvasive Carcinoma
D002575 Uterine Cervicitis Inflammation of the UTERINE CERVIX. Cervicitis,Cervicitides,Cervicitides, Uterine,Cervicitis, Uterine,Uterine Cervicitides
D002578 Uterine Cervical Dysplasia Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE. Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervix Dysplasia,Dysplasia of Cervix Uteri,Neoplasia, Cervical Intraepithelial,Cervical Intraepithelial Neoplasia, Grade III,Cervical Intraepithelial Neoplasms,Intraepithelial Neoplasia, Cervical,Cervical Dysplasia, Uterine,Cervical Dysplasias,Cervical Intraepithelial Neoplasm,Cervix Uteri Dysplasia,Cervix Uteri Dysplasias,Dysplasia, Cervical,Dysplasia, Cervix,Dysplasia, Uterine Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
August 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
April 1975, Cellular immunology,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
December 1989, Der Internist,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
January 1979, Advances in experimental medicine and biology,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
January 1976, Bollettino dell'Istituto sieroterapico milanese,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
January 1975, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
May 1989, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
January 1992, Archivum veterinarium Polonicum,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
May 1983, Scandinavian journal of haematology,
Spivak MYa, and V P Lakatosh, and L M Lazarenko, and L M Lyanenko, and M V Azarskova, and O M Mikhailenko, and L Tkáciková, and A M Boroda
April 1980, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!